Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
26.03
+3.46 (15.33%)
At close: Feb 4, 2025, 4:00 PM
25.03
-1.00 (-3.84%)
After-hours: Feb 4, 2025, 7:28 PM EST
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $96.61 million as of February 4, 2025. Its market cap has increased by 86.86% in one year.
Market Cap
96.61M
Enterprise Value
30.82M
1-Year Change
86.86%
Ranking
Category
Stock Price
$26.03
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $96.61M, a decrease of -82.54%. That is a compound annual growth rate of -33.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2025 | 83.77M | -43.35% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | 1.05B | 90.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.82B |
| UnitedHealth Group | 501.97B |
| Johnson & Johnson | 369.55B |
| Novo Nordisk | 366.04B |
| AbbVie | 335.67B |
| Merck & Co. | 229.54B |
| Abbott Laboratories | 223.92B |
| Thermo Fisher Scientific | 222.07B |